drugset / Trial / NCT00006205

Alcohol Dependency Study: Combining Medication Treatment for Alcoholism

NCT00006205

RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of this study is to learn whether ondansetron and topiramate either alone or in combination is safe and effective in the treatment of alcohol dependence. This 13 week out-patient clinical trial is randomized, double-blind, and placebo-controlled. There are post-study follow up visits 1, 2 and 3 months after the end of the study. Participants will receive ondansetron and topiramate either alone or in combination or a placebo coupled with psychotherapy.

Timeline

Start
2005-03
Primary completion
2013-06
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 ug/kg
Subject Topiramate Small molecule 300 mg

Indications